// App-Quantinova.ai

2152 : Characterisation of co-expression of CD39 with other IO-relevant markers on major T/NK cell TIL subsets

Researchers

Presenter

  • Jim Hair

Principal Investigators

  • Nadia Luheshi

  • Simon J. Dovedi

  • Robert W. Wilkinson

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Melanoma

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • 5'-nucleotidase

  • Natural Killer cells

  • Cluster of Differentiation 4

  • Programmed cell death protein 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved